Congenital disordersBeyond Binary: Gender Reassignment in a Case of 11β-Hydroxylase Deficiency Posted on November 10, 2023November 11, 2023 by yun 10 Nov Specialty yun Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease 85-year-old donates his 10th gallon of blood
